Crispr Therapeutics
Price & Volume
Stats
See more52W Range | $44.12-$75.06 |
Market Cap | $5.1B |
Shares Short | 18M |
Financials
See moreRevenue (12 Mos) | $13.3M |
Revenue Growth (YoY) | 1,041.4% |
Gross Profit (12 Mos) | -$461.8M |
Diluted EPS | -$4.74 |
News
See moreYahoo Finance • 20 days ago
Billionaire Ken Fisher Was Buying These 2 Cathie Wood Stocks
Yahoo Finance • 20 days ago
Autologous Hematopoietic Stem Cell Gene Therapy Market Global Report 2026: A $13.44 Billion Market by 2030 as Novartis, Vertex, CRISPR Therapeutics and Orchard Therapeutics Accelerate the Gene-Editing Race
Yahoo Finance • 23 days ago
3 Reasons CRISPR Therapeutics Stock Is Still a Buy After a Rocky 2026
Yahoo Finance • 28 days ago
Cathie Wood Makes Striking Switch Between AI Stock Giants
About
CEO | Dr. Samarth Kulkarni Ph.D. |
Address | Baarerstrasse 14, Zug, Switzerland, 6300 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 393 |